skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: New selenium-75 labeled radiopharmaceuticals: selenonium analogues of dopamine

Journal Article · · J. Med. Chem.; (United States)
DOI:https://doi.org/10.1021/jm00361a003· OSTI ID:6826748

Selenium-75 labeled selenonium analogues of dopamine, (2-(3,4-dimethoxyphenyl)ethyl)dimethylselenonium iodide and its dihydroxy analogue, were prepared by reducing (/sup 75/Se)selenious acid with sodium borohydride at pH 6.0 and reacting the NaSeH produced with 1-(3,4-dimethoxyphenyl)-2-(p-toluenesulfonyloxy)ethane. Tissue distribution studies in rats given the /sup 75/Se-labeled selenonium agents intravenously demonstrated high initial heart uptake. Prolonged adrenal retention and high adrenal to blood ratio of compound 4 were observed. The high uptake and adrenal to blood ratio suggest the potential use of compound 4 as a radiopharmaceutical for the adrenal gland.

Research Organization:
Univ. of Oklahoma, Oklahoma City
OSTI ID:
6826748
Journal Information:
J. Med. Chem.; (United States), Vol. 26:7
Country of Publication:
United States
Language:
English